Mesoblast to Host Analyst Call on Results of End-Stage Heart Failure Trial Being Presented at 2018 American Heart Association Scientific Sessions

World News: . []

NEW YORK and MELBOURNE Australia Nov 09 2018 GLOBE NEWSWIRE) -- Mesoblast Limited NasdaqMESO (ASX:MSB) will host a webcast to discuss the results of the Phase 2b trial evaluating its allogeneic mesenchymal precursor cell product candidate MPC-150...

More news and information about Mesoblast Limited

Published By:

Globe Newswire: 11:00 GMT Friday 9th November 2018

Published: .

Search for other references to "mesoblast" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us